An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor
Article in Science Translational Medicine (June 2023)
The most recent citing publications are shown below. View all 36 publications that cite this research output on Dimensions.
Article in Science Translational Medicine (June 2023)
Article in Journal of Molecular and Cellular Cardiology (December 2022)
Article in Frontiers in Physiology (June 2022)